SRT3 Sartorius Aktiengesellschaft

325.47USD296.10 EUR · XETRA-0.97%Mkt Cap: 22.69B USDP/E: 94.62

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometr…

Institutional holders11 on file

Key Statistics

Company
Market Cap22.69B USD
Enterprise Value28.07B USD
Revenue (TTM)4.03B USD
Gross Profit1.80B USD
Net Income (TTM)170.27M USD
Revenue/Share56.33 USD
Last Price325.47 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees14.3K
CountryDE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINDE0007165631
Valuation
P/E (Trailing)94.62
P/E (Forward)46.16
PEG0.94
EV/EBITDA26.11
EV/Revenue6.97
P/S5.63
P/B7.63
EPS (TTM)3.47 USD
EPS (Forward)7.12 USD
52W Range
218.1991% of range335.70
52W High335.70 USD
52W Low218.19 USD
Profitability
Gross Margin46.26%
Oper. Margin17.80%
EBITDA Margin26.69%
Profit Margin4.38%
ROE5.72%
ROA1.59%
ROIC5.12%
ROCE7.34%
Growth
Revenue Growth9.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF920.03M USD
CapEx (TTM)485.74M USD
FCF Margin10.38%
FCF Yield1.84%
Net Debt4.04B USD
Net Debt/EBITDA3.76
Net Debt/FCF9.67
Balance Sheet
Debt/Equity1.58
Current Ratio1.07
Quick Ratio0.42
Book Value/Sh43.09 USD
Cash/Share3.67 USD
Dividends
Fwd Div Rate0.81 USD
Trail. Div Rate0.81 USD
Div. Yield0.25%
5Y Avg Yield0.31%
Payout Ratio23.42%
Ex-Div DateMar 27, 2026
Pay Date—
Splits
Last Split4:1
Split DateJun 13, 2016
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)332.12 USD
Upside (mean)+2.0%
Target Range219.84 USD – 434.18 USD
219.84+2.0% to mean434.18
# Analysts21
Ownership
Shares Out.34.81M
Float27.45M
Insiders25.61%
Institutions30.67%
Technical
SMA 50294.19 (+10.6%)
SMA 200261.31 (+24.6%)
Beta1.51
S&P 52W Chg12.00%
Avg Vol (30d)110.44K
Avg Vol (10d)83.80K
Technical Indicators
RSI (14)65.5
MACD7.3001
MACD Signal8.1028
MACD Hist.-0.8027
BB Upper329.45 USD
BB Middle320.59 USD
BB Lower311.72 USD
BB Width5.53%
ATR (14)9.082 USD
Vol Ratio (20d)0.91x

About Sartorius (ETR: SRT3)

›

Sartorius (ETR: SRT3) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 14,273 employees.

The shares were at 296.10 EUR on 20 November 2026, up 31.5% over 52 weeks. Its 52-week range is 198.50 EUR to 305.40 EUR: the price is 3.0% below the high and 49.2% above the low.

At a market capitalisation of 20.65B EUR, it trades at 94.6 times trailing earnings and 46.2 times forward earnings. The median trailing P/E of its 17 largest Medical Instruments & Supplies peers is 47.0, a premium of 101% for SRT3. It pays a dividend yielding 0.25% (it pays out 23% of its earnings), against a median of 1.05% among the dividend payers in that peer group.

Sartorius reports return on equity of 5.7%, an operating margin of 17.8% and revenue up 9.9% year over year.

Its debt exceeds its cash by 3.68B EUR, a debt-to-equity ratio of 1.58. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 21 analysts cover the stock, with an average rating of Buy; their mean price target of 302.14 EUR is 2.0% above the current price.